UBS Group’s Forte Biosciences FBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13 Sell
1
-526
-100% -$6.84K ﹤0.01% 8812
2025
Q1
$4.09K Buy
+527
New +$4.09K ﹤0.01% 7833
2024
Q4
Sell
-1,606
Closed -$8.98K 8769
2024
Q3
$8.98K Buy
1,606
+634
+65% +$3.54K ﹤0.01% 6602
2024
Q2
$13.1K Buy
972
+971
+97,100% +$13K ﹤0.01% 6413
2024
Q1
$23 Sell
1
-5
-83% -$115 ﹤0.01% 7846
2023
Q4
$120 Sell
6
-93
-94% -$1.86K ﹤0.01% 7682
2023
Q3
$1.64K Buy
99
+98
+9,800% +$1.62K ﹤0.01% 6730
2023
Q2
$34 Sell
1
-380
-100% -$12.9K ﹤0.01% 7559
2023
Q1
$9.62K Buy
381
+312
+452% +$7.87K ﹤0.01% 6544
2022
Q4
$1.72K Buy
69
+68
+6,800% +$1.69K ﹤0.01% 8609
2022
Q3
$0 Sell
1
-75
-99% ﹤0.01% 9337
2022
Q2
$2K Sell
76
-11
-13% -$289 ﹤0.01% 8497
2022
Q1
$3K Sell
87
-374
-81% -$12.9K ﹤0.01% 8378
2021
Q4
$25K Buy
461
+449
+3,742% +$24.3K ﹤0.01% 6467
2021
Q3
$1K Sell
12
-13
-52% -$1.08K ﹤0.01% 8019
2021
Q2
$21K Buy
25
+13
+108% +$10.9K ﹤0.01% 6185
2021
Q1
$10K Sell
12
-16
-57% -$13.3K ﹤0.01% 6891
2020
Q4
$26K Buy
28
+1
+4% +$929 ﹤0.01% 5737
2020
Q3
$34K Buy
+27
New +$34K ﹤0.01% 5052
2020
Q2
Sell
-56
Closed -$26K 7123
2020
Q1
$26K Sell
56
-48
-46% -$22.3K ﹤0.01% 5422
2019
Q4
$21K Buy
104
+60
+136% +$12.1K ﹤0.01% 5775
2019
Q3
$11K Buy
44
+24
+120% +$6K ﹤0.01% 6129
2019
Q2
$50K Buy
20
+4
+25% +$10K ﹤0.01% 5067
2019
Q1
$67K Sell
16
-18
-53% -$75.4K ﹤0.01% 4538
2018
Q4
$105K Buy
34
+6
+21% +$18.5K ﹤0.01% 4621
2018
Q3
$162K Buy
28
+9
+47% +$52.1K ﹤0.01% 4373
2018
Q2
$66K Hold
19
﹤0.01% 4883
2018
Q1
$85K Buy
+19
New +$85K ﹤0.01% 4496
2017
Q4
Sell
-1
Closed -$3K 6876
2017
Q3
$3K Sell
1
-3
-75% -$9K ﹤0.01% 6465
2017
Q2
$17K Buy
+4
New +$17K ﹤0.01% 5465